Search results
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India, Makes Way For Domestic Generic...
Benzinga via Yahoo Finance· 1 year agoThe Indian Patent Office rejected Johnson and Johnson's (NYSE: JNJ) application to extend its patent...